Phase II Study of Folotyn With Leucovorin to Prevent/Reduce Mucositis in Patients With Hematological Malignancies Read more about Phase II Study of Folotyn With Leucovorin to Prevent/Reduce Mucositis in Patients With Hematological Malignancies
An Expanded Access Program With Lenvatinib for the Treatment of Radioiodine-Refractory Differentiated Thyroid Cancer Read more about An Expanded Access Program With Lenvatinib for the Treatment of Radioiodine-Refractory Differentiated Thyroid Cancer
A Study of BIND-014 (Docetaxel Nanoparticles for Injectable Suspension) as Second-line Therapy for Patients With KRAS Positive or Squamous Cell Non-Small Cell Lung Cancer Read more about A Study of BIND-014 (Docetaxel Nanoparticles for Injectable Suspension) as Second-line Therapy for Patients With KRAS Positive or Squamous Cell Non-Small Cell Lung Cancer
Efficacy and Safety of Grass-SPIRE Registration Study Read more about Efficacy and Safety of Grass-SPIRE Registration Study
CTL019 Out of Specification MAP for ALL or DLBCL Patients Read more about CTL019 Out of Specification MAP for ALL or DLBCL Patients
PF-06952229 Treatment in Adult Patients With Advanced Solid Tumors Read more about PF-06952229 Treatment in Adult Patients With Advanced Solid Tumors
The BURAN Study of Buparlisib in Patients With Recurrent or Metastatic HNSCC Read more about The BURAN Study of Buparlisib in Patients With Recurrent or Metastatic HNSCC
Testing the Use of the Usual Chemotherapy Before and After Surgery for Removable Pancreatic Cancer Read more about Testing the Use of the Usual Chemotherapy Before and After Surgery for Removable Pancreatic Cancer
To Evaluate Efficacy and Safety of Parsaclisib and Ruxolitinib in Participants With Myelofibrosis Who Have Suboptimal Response to Ruxolitinib (LIMBER-304) Read more about To Evaluate Efficacy and Safety of Parsaclisib and Ruxolitinib in Participants With Myelofibrosis Who Have Suboptimal Response to Ruxolitinib (LIMBER-304)
A Study to Evaluate Tabelecleucel in Participants With Epstein-barr Virus-associated Diseases Read more about A Study to Evaluate Tabelecleucel in Participants With Epstein-barr Virus-associated Diseases